Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients-Reference-Cited by-同舟云学术

Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients

Published:2021-10 Issue: Volume:519 Page:105-116
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Jacquier Alix^ORCID,Lambert Tiphaine,Delattre Jean-François,Djouadou Malika,Vérine Jérôme,Dumont Clément,Desgrandchamps François,Carosella Edgardo D.,LeMaoult Joel,Rouas-Freiss Nathalie

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. CD4+ T cell help in cancer immunology and immunotherapy;Borst;Nat. Rev. Immunol.,2018

2. Emergence of a CD4+CD28− granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection;van Leeuwen;J. Immunol.,2004

3. The transcription factor Hobit identifies human cytotoxic CD4+ T cells;Oja;Front. Immunol.,2017

4. Characterization of CD4+ CTLs ex vivo;Appay;J. Immunol.,2002

5. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma;Fu;Hepatology,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of HLA-G in tumors and upon COVID-19 infection;Human Immunology;2024-05

2. Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study;BMC Cancer;2024-04-09

3. CTLs heterogeneity and plasticity: implications for cancer immunotherapy;Molecular Cancer;2024-03-21

4. The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023;The Oncologist;2023-12-04

5. The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy;Biomolecules;2023-08-03